808 Exploring resistance mechanism to pembrolizumab and ang-2 inhibitor trebananib (NCT03239145) using high-dimensional single-cell mass cytometry (CyTOF)

Subjects

Subjects :

Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282

Details

Language :

English

ISSN :

20511426

Volume :

8

Issue :

Suppl 3

Database :

Directory of Open Access Journals

Journal :

Journal for ImmunoTherapy of Cancer

Publication Type :

Academic Journal

Accession number :

edsdoj.bb13f9b6739d4ca29f20d134aa05013b

Document Type :

article

Full Text :

https://doi.org/10.1136/jitc-2020-SITC2020.0808